A CLINICAL TRIAL TO STUDY THE EFFICACY OF HOMOEOPATHIC MEDICINE IN PREVENTION AND CURE OF CORONA VIRUS DISEASE 19

PROVING THE EFFICACY OF HOMOEOPATHIC TREATMENT IN PREVENTION AND CURE OF COVID 19

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025049

Enrollment

100

Registered

2020-05-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: ARSENIC ALBUM 30: HOMOEOPATHIC MEDICINE ARSENIC ALBUM IN POTNTISED FORM OF 30 CENTICIMAL POTENCY OD DAILY FOR 3 DAYS Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: MALES OR FEMALES WITH A DIAGNOSIS OF COVID 19 AND MALES OR FEMALES QUARANTINE PERSON FOR COVID 19

Exclusion criteria

Exclusion criteria: NIL

Design outcomes

Primary

Measure	Time frame
Primary endpoint of this trial will be measured in terms of clinically recovered cases (covid 19 negative)or deathTimepoint: 1 MONTH	—

Secondary

Measure	Time frame
Improvement in the quality of life w.r.t. activity, appetite , sleep and general condition of patient. fever clearance , changes in severity of symptoms, resolution of pneumoniaTimepoint: every 7 days;Suspected cases in quarantine confirmed as negativeTimepoint: 14 days	—

Countries

India

Contacts

Public ContactDR DHIRENDRA TIWARI

SAI NIDAN HOMOEOPATHY CLINIC

drdhiren16@yahoo.co.in8770568212

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026